Publications and ressources

Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunity.

Source :

Pmid / DOI:

Trial of Spesolimab for Generalized Pustular Psoriasis.

Hervé Bachelez

Source :

Pmid / DOI:

SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist.

Hervé Bachelez

Source :

Pmid / DOI:

Anti-Saccharomyces cerevisiae IgG and IgA antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa.

Florence Assan , Asma Smahi, Hervé Bachelez

Source :

Pmid / DOI:

Mutations in PERP Cause Dominant and Recessive Keratoderma.

Alain Hovnanian

Source :

Pmid / DOI:

EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa.

Alain Hovnanian

Source :

Pmid / DOI:

Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair.

Alain Hovnanian

Source :

Pmid / DOI:

A TP63 mutation causes prominent alopecia with mild ectodermal dysplasia.

Alain Hovnanian , Patrick Nitschké, Christine Bole

Source :

Pmid / DOI:

APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.

Alain Hovnanian

Source :

Pmid / DOI:

Intradermal Injection of Bone Marrow Mesenchymal Stromal Cells Corrects Recessive Dystrophic Epidermolysis Bullosa in a Xenograft Model.

Alain Hovnanian

Source :

Pmid / DOI:

Intradermal Injection of Bone Marrow Mesenchymal Stromal Cells Corrects Recessive Dystrophic Epidermolysis Bullosa in a Xenograft Model.

Source :

Pmid / DOI:

Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial.

Alain Hovnanian

Source :

Pmid / DOI:

Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model.

Alain Hovnanian

Source :

Pmid / DOI:

Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum.

Alain Hovnanian

Source :

Pmid / DOI:

Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.

Alain Hovnanian

Source :

Pmid / DOI: